Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04799535 · ClinicalTrials.gov registry record
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
A clinical trial of Breast Carcinoma and Breast Neoplasm, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 550
- Enrollment target
- 1
- Study location
NCT04799535 is a study of Breast Carcinoma and Breast Neoplasm that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 550 participants, below the 765-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04799535, a study of Breast Carcinoma and Breast Neoplasm, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 550 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effectiveness of a breast ultrasound method for the diagnosis of breast cancer. Diagnostic procedures, such as breast ultrasound, may help find and diagnose breast cancer, and may help measure a patient's response to earlier treatment. The purpose of this research is to test the effectiveness of a new investigational breast ultrasound method to detect an abnormality in the breast, and assess response to breast cancer treatment.
Conditions Studied
Interventions
- PROCEDURE Ultrasound
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2027-11-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04799535
The ClinicalTrials.gov registry entry for NCT04799535 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 765-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (28% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.
NCT04799535 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04799535 about?
NCT04799535 is a clinical study titled "Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring". This study evaluates the effectiveness of a breast ultrasound method for the diagnosis of breast cancer. Diagnostic procedures, such as breast ultrasound, may help find and diagnose breast cancer, and may help measure a patient's response to earlier treatment. The purpose of this research is to test...
What is the current status of trial NCT04799535?
This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2019-09-01. Estimated completion is 2027-11-29.
What conditions does trial NCT04799535 study?
This clinical trial studies the following conditions: Breast Carcinoma, Breast Neoplasm.
What interventions are being tested in trial NCT04799535?
The interventions under investigation include: Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT04799535?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04799535 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surviving Daily Life
RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
RECRUITING
-
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
RECRUITING · Phase 2
-
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
RECRUITING · Phase 2
-
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
RECRUITING
-
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.